GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NanoRepro AG (XTER:NN6) » Definitions » Net Income From Continuing Operations

NanoRepro AG (XTER:NN6) Net Income From Continuing Operations : €-5.85 Mil (TTM As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is NanoRepro AG Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. NanoRepro AG's net income from continuing operations for the six months ended in Jun. 2024 was €-1.17 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2024 was €-5.85 Mil.

NanoRepro AG Net Income From Continuing Operations Historical Data

The historical data trend for NanoRepro AG's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoRepro AG Net Income From Continuing Operations Chart

NanoRepro AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.19 1.70 29.72 -3.72 -4.69

NanoRepro AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 -3.93 - -4.68 -1.17

NanoRepro AG Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-5.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NanoRepro AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NanoRepro AG (XTER:NN6) » Definitions » Net Income From Continuing Operations
Comparable Companies
TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT LH DGX XPAR:BIM ILMN XPAR:ERF EXAS RVTY ICLR QGEN MEDP
Traded in Other Exchanges
NN6:Germany NN6:Germany NN6:Germany
Address
Untergasse 8, Marburg, DEU, 35037
Website
https://www.nanorepro.com
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
Executives
Dr. Olaf Stiller Supervisory Board
Andre Schulte-südhoff Supervisory Board
Lisa Jüngst Board of Directors
Michael Tillmann Supervisory Board

NanoRepro AG Headlines

No Headlines